Zepbound

Zepbound is a dual GIP and GLP‑1 receptor agonist designed for chronic weight management in adults with obesity (BMI ≥ 30) or overweight (BMI ≥ 27) with at least one weight-related condition. It’s also approved to treat moderate-to-severe obstructive sleep apnea in adults with obesity  Zepbound offers a powerful, clinically validated option for weight loss and sleep apnea improvement in individuals with obesity, providing significantly greater reductions in body weight compared to placebo and GLP‑1 alone.